Mitsubishi UFJ Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$192K Buy
2025
Q1
$163K Buy
2024
Q4
$221K Buy
2024
Q3
$134K Sell
2024
Q2
$167K Sell
2024
Q1
$248K Sell
2023
Q4
$252K Sell
2023
Q3
$252K Buy
2023
Q2
$232K Buy
2023
Q1
$139K Buy
2022
Q4
$141K Buy
2022
Q2
Sell
2022
Q1
$117K Buy
2021
Q4
$270K Buy